Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Multicenter, Dose-Optimized, Randomized, Double Blind, Efficacy and Safety Study With Azstarys® in Children 4 to 12 Years of Age With Attention Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockAn Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.
Read the official source — NCT00307619Randomized, Double-blind Placebo Controlled Trial With Topiramate for the Treatment of Obese Patients With Binge Eating Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedAn Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
Read the official source — NCT01060150Efficacy and Learning Skill After OROS Methylphenidate Treatment in Adolescents With Attention-Deficit/Hyperactivity Disorder: A 12-week, Multi-center, Open-label Study
This study has finished and is no longer accepting participants.
Location not clearly listedAn Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia
Read the official source — NCT01662310Paliperidone Extended Release Tablets for the Prevention of Relapse in Subjects With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
This study has finished and is no longer accepting participants.
Multiple locations, including Baoding
A longitudinal study of two dissemination strategies for the enhanced Aussie Optimism: Social Life Skills and Optimistic Thinking Skills programs in preventing social and emotional problems, anxiety and depressive disorders, and suicidal ideation in 10-11 years old children in 63 Government Primary Schools in Perth, Western Australia.
This study has finished and is no longer accepting participants.
In AustraliaAn Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia
Read the official source — NCT00460512Researchers studied Paliperidone ER to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AntwerpResearchers compared JNJ-42165279 and placebo to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Costa Mesa
This study has finished and is no longer accepting participants.
In Kansas CityFeasibility of a Therapist and Parent Guided eHealth Intervention for Obsessive Compulsive Disorder in Youth With Autism Spectrum Disorder
This study has finished and is no longer accepting participants.
In StockholmAn eHealth Intervention to Increase Depression Treatment Initiation and Adherence Among Veterans Referred for Mental Health Services (CDA 18-189)
This study has finished and is no longer accepting participants.
In HinesThis study has finished and is no longer accepting participants.
In AustraliaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FinlandWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.